Skip to content

Clinical trials

Phase 2/3 trials in the United Arab Emirates

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: United Arab Emirates Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20225
20241
20253
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Recruiting4
Active, not recruiting3
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Bristol-Myers Squibb1
Cellcolabs Clinical SPV Limited1
Fakih IVF Fertility Center1
Mohammed Bin Rashid University of Medicine and Health Sciences1
Napo Pharmaceuticals, Inc.1
Resverlogix Corp1
Sanofi1
Sheikh Khalifa Medical City1
Suzhou Abogen Biosciences Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-192
Breast Neoplasms1
Bronchiolitis1
Colitis, Ulcerative1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities1
Crohn Disease1
Dermatitis, Atopic1
Epidermolysis Bullosa Simplex1
Inflammatory Bowel Diseases1
Post-Acute COVID-19 Syndrome1

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.